Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Aug 11, 2017
    FDA Research Points To Change in DTC TV Ads
  • Aug 10, 2017
    Analysis Details Opioid-related Industry Payments Made to Physicians
  • Aug 10, 2017
    Recent Court Decisions Illustrate Central Hudson Test
  • Aug 9, 2017
    New Hampshire Files Lawsuit Against Purdue Pharma
  • Aug 9, 2017
    OPDP Researchers Tackle DTC Ad Issues
  • Aug 4, 2017
    Study Finds Increase in DTC Viewership Translates to Increased Sales
  • Aug 2, 2017
    Pharma Reps Need To Keep It Fresh
  • Jul 27, 2017
    Celgene $280 Million Settlement Resolves False Claims Allegations Based on Cancer Drugs' Promotion
  • Jul 18, 2017
    FDA Alters Character-limited Study Based on Comments
  • Jul 18, 2017
    Commercial Support of CME Keeps Rising
  • More

Good Clinical Practice

  • Dec 22, 2017
    Partnership Looks To Improve Minority Participation in Lupus Research
  • Dec 22, 2017
    Expert Group Offers SAP Essential Items
  • Dec 21, 2017
    FDA Debars Clinical Investigator
  • Dec 20, 2017
    FDA Closes Orphan Drug Loophole
  • Dec 19, 2017
    FDA Issues Draft Guidance To Aid Trials for Targeted Medicines
  • Dec 19, 2017
    FDA Plans Direct Final Rule Allowing IRBs to Waive Consent for Some Minimal Risk Studies
  • Dec 18, 2017
    ClinicalTrials.gov Adds User-friendly Features
  • Dec 18, 2017
    Bioethicists Call for Fetal Therapy Trials
  • Dec 18, 2017
    FDA Research Finds Older Subjects Underrepresented in Blood Cancer Trials
  • Dec 18, 2017
    Securities Fraud Involves Trial Results
  • More

U.S. Food Labeling

  • Mar 31,2012
    Members of House and Senate Ask FDA for Mandatory Labeling of Biotech Foods
  • Mar 31,2012
    Get Your Newsletter Faster Online!
  • Mar 31,2012
    Coming Soon from FSIS: Labels for Tenderized Cuts
  • Mar 31,2012
    FDA Tells Industry that Front-of-Pack Labeling Program Will Not Trigger Agency Enforcement
  • Feb 29,2012
    Rep. DeLauro Urges New Labeling for Added Sugars
  • Feb 29,2012
    Get Your Newsletter Faster Online!
  • Feb 29,2012
    Vermont Introduces Legislation on GE Labeling
  • Feb 29,2012
    Walmart and Kellogg Launch New Front-of-Pack Labeling Icons as FDA Sits on Sidelines
  • Feb 29,2012
    Average Sodium Consumption in U.S. Much Higher Than Recommended, Says CDC Report
  • Feb 29,2012
    NAD Says Cookie Maker Can Make Ad Claims
  • More

FDA Regulation & Enforcement

  • Jul 23, 2020
    FDA Greenlights Qualified Health Claim for Cranberries, UTI Link
  • Jul 20, 2020
    FDA Delays Enforcement of Premarket Approval Mandates for Some HCT/Ps Through May 2021 Due to COVID-19
  • Jul 20, 2020
    OPDP Posts Three Case Studies To Help HCPs Identify ‘Bad Ads’
  • Jul 15, 2020
    Inspections of Small Businesses Subject to FSMA Intentional Adulteration Rule To Begin in March 2021
  • Jul 10, 2020
    FDA To Use COVID-19 Risk Assessment System As It Restarts Domestic Inspections; Most Will Be Preannounced
  • Jul 10, 2020
    OPDP Researchers Plan Three New Studies
  • Jul 9, 2020
    CEO Pleads Guilty to Misbranding Charge Under Park Doctrine for Misrepresentation of Drug’s Safety Risks
  • Jul 9, 2020
    NBFDS Final Guidances, FAQs Available on Validating Refining Process, Testing Methods
  • Jul 3, 2020
    Novartis To Pay Nearly $700 Million To Settle Speaker Program and Co-Pay Cases
  • Jul 1, 2020
    Novartis, Subsidiaries Settle Foreign Corrupt Practices Act Allegations for Over $345 Million
  • More

Medical Devices

  • Nov 18, 2014
    CRM Device Maker Settles Kickback Allegations in False Claims Act Suit for $4.9 Million
  • Nov 13, 2014
    Import Detention Lifted After Distributors of Leg Brace Sue To Block FDA’s ‘Illegal’ Action
  • Nov 12, 2014
    District Court Refuses To Dismiss Government’s Allegations Against Spinal Device Maker, PODs
  • Nov 6, 2014
    Final Guidance on Device Recalls, Enhancements Addresses Issues Raised in Criticism of 2013 Draft
  • Nov 4, 2014
    HHS OIG Work Plan Outlines Device-related Projects for FY 2015
  • Oct 29, 2014
    FDA Shows Improved PMA Review Times While 510(k) Delays, Lag Behind EU Approvals Persist
  • Oct 22, 2014
    CDRH-ORA Action Plan Calls for Device Inspectors Specializing in Product Quality
  • Oct 14, 2014
    Final Cybersecurity Guidance Holds to FDA Expectations for Industry
  • Oct 9, 2014
    CDRH Webinar To Discuss Recently Finalized Custom Device Guidance
  • Oct 1, 2014
    CDRH Reports Increase in Foreign QS Inspections During 2013; U.S. Inspections Drop by 6.35 Percent
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.